General Information of the Protein
Protein ID
PT02590
Protein Name
N-formyl peptide receptor 2
Secondarily
Protein Name
FMLP-related receptor I
Formyl peptide receptor-like 1
HM63
Lipoxin A4 receptor
RFP
Gene Name
FPR2
Secondarily
Gene Name
FPRH1
FPRL1
LXA4R
Sequence
METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
N-formyl methionyl peptide receptor
Function
Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophil chemotactic factors (PubMed:1374236). Binding of FMLP to the receptor causes activation of neutrophils (PubMed:1374236). This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:1374236). The activation of LXA4R could result in an anti-inflammatory outcome counteracting the actions of pro-inflammatory signals such as LTB4 (leukotriene B4) (PubMed:9547339). Receptor for the chemokine-like protein FAM19A5, mediating FAM19A5-stimulated macrophage chemotaxis and the inhibitory effect on TNFSF11/RANKL-induced osteoclast differentiation (By similarity). Acts as a receptor for humanin (PubMed:15465011).
    Show/Hide
Uniprot ID
Primary ID:
P25090

Secondarily ID:
A8K3E2
    Show/Hide
Ensembl ID
ENSG00000171049
HGNC ID
HGNC:3827
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0545821
1-[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-phenylurea
   Show/Hide
C18H17F2N3O3
 1
1
EC50 = 5 nM
   TI
   LI
   LO
   TS
CP0546958
(3S,4R)-3-[[5-(4-chlorophenyl)-1,2-oxazol-3-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C20H16ClF2N3O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0395312
1-(3-tert-butyl-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-chlorophenyl)urea
   Show/Hide
C21H23ClN4O2
 1
1
EC50 = 23 nM
   TI
   LI
   LO
   TS
CP0374845
1-(3-isopropyl-2-methyl-5-oxo-1-(quinolin-3-yl)-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(methylthio)phenyl)urea
   Show/Hide
C24H25N5O2S
 1
1
EC50 = 30 nM
   TI
   LI
   LO
   TS
CP0525163
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-iodophenyl)urea
   Show/Hide
C18H17IN4O2
 1
1
EC50 = 30 nM
   TI
   LI
   LO
   TS
CP0569103
(3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O3
 1
1
EC50 = 32 nM
   TI
   LI
   LO
   TS
CP0446518
2-ethyl-1-[(3R)-1-[(5-methoxy-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C23H24N4O2
 1
1
EC50 = 34 nM
   TI
   LI
   LO
   TS
CP0580015
(3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O2S
 1
1
EC50 = 37 nM
   TI
   LI
   LO
   TS
CP0580225
(3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2-fluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H16ClFN4O3
 1
1
EC50 = 40 nM
   TI
   LI
   LO
   TS
CP0965302
(3R,4R)-3-(6-chloro-3H-imidazo[4,5-b]pyridin-2-yl)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C17H13ClF2N4O2
 1
1
EC50 = 40 nM
   TI
   LI
   LO
   TS
CP0541744
1-(3-isopropyl-2-methyl-5-oxo-1-(pyrimidin-5-yl)-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(methylthio)phenyl)urea
   Show/Hide
C19H22N6O2S
 1
1
EC50 = 43 nM
   TI
   LI
   LO
   TS
CP0259831
1-(4-chlorophenyl)-3-[1-methyl-3-oxo-2-phenyl-5-(propan-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]urea
   Show/Hide
C20H21ClN4O2
 1
1
EC50 = 44 nM
   TI
   LI
   LO
   TS
CP0374827
1-(3-isopropyl-2-methyl-5-oxo-1-(quinolin-3-yl)-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(trifluoromethyl)phenyl)urea
   Show/Hide
C24H22F3N5O2
 1
1
EC50 = 44 nM
   TI
   LI
   LO
   TS
CP0579427
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-[4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one
   Show/Hide
C20H15F5N4O4
 1
1
EC50 = 53 nM
   TI
   LI
   LO
   TS
CP0499716
1-(4-chlorophenyl)-3-(3-isopropyl-2-methyl-5-oxo-1-(quinolin-3-yl)-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C23H22ClN5O2
 1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0522966
1-(3-fluoro-4-methylphenyl)-3-(3-isopropyl-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C21H23FN4O2
 1
1
EC50 = 81 nM
   TI
   LI
   LO
   TS
CP0532343
1-(3-tert-butyl-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(3-fluoro-4-methylphenyl)urea
   Show/Hide
C22H25FN4O2
 1
1
EC50 = 83 nM
   TI
   LI
   LO
   TS
CP0395322
1-(4-bromophenyl)-3-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C18H17BrN4O2
 1
1
EC50 = 90 nM
   TI
   LI
   LO
   TS
CP0529099
1-(2-ethyl-3-isopropyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(3-fluoro-4-methylphenyl)urea
   Show/Hide
C22H25FN4O2
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0542272
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(trifluoromethyl)phenyl)urea
   Show/Hide
C19H17F3N4O2
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0969958
(3R,4R)-3-(5-chloro-1H-benzo[d]imidazol-2-yl)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C18H14ClF2N3O2
 1
1
EC50 = 110 nM
   TI
   LI
   LO
   TS
CP0509978
2-ethyl-1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl}-1H-1,3-benzodiazole
   Show/Hide
C23H24N4O2
 1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
CP0506065
1-(4-chlorophenyl)-3-(3-ethyl-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C19H19ClN4O2
 1
1
EC50 = 140 nM
   TI
   LI
   LO
   TS
CP0541743
1-(3-isopropyl-2-methyl-5-oxo-1-(pyrimidin-5-yl)-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(trifluoromethyl)phenyl)urea
   Show/Hide
C19H19F3N6O2
 1
1
EC50 = 150 nM
   TI
   LI
   LO
   TS
CP0574646
(3S,4R)-3-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H17ClN4O3
 1
1
EC50 = 160 nM
   TI
   LI
   LO
   TS
CP0393825
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(methylthio)phenyl)urea
   Show/Hide
C19H20N4O2S
 1
1
EC50 = 170 nM
   TI
   LI
   LO
   TS
CP0496722
1-(4-chlorophenyl)-3-(3-isopropyl-2-methyl-5-oxo-1-(pyrimidin-5-yl)-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C18H19ClN6O2
 1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS
CP0578828
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]pyrrolidin-2-one
   Show/Hide
C19H16F2N4O3
 1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS
CP0580081
(3S,4R)-3-[[5-(4-chlorophenyl)-1,3-oxazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C20H16ClF2N3O3
 1
1
EC50 = 250 nM
   TI
   LI
   LO
   TS
CP0399583
2-ethyl-1-[(3R)-1-[(5-ethyl-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C24H26N4O
 1
1
EC50 = 270 nM
   TI
   LI
   LO
   TS
CP0442117
1-(3-ethyl-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(3-fluoro-4-methylphenyl)urea
   Show/Hide
C20H21FN4O2
 1
1
EC50 = 310 nM
   TI
   LI
   LO
   TS
CP0252495
1-(4-chlorophenyl)-3-(1,5-dimethyl-3-oxidanylidene-2-phenyl-pyrazol-4-yl)urea
   Show/Hide
C18H17ClN4O2
 1
1
EC50 = 490 nM
   TI
   LI
   LO
   TS
CP0522965
1-(4-chlorophenyl)-3-(1-(4,5-dihydrothiazol-2-yl)-3-isopropyl-2-methyl-5-oxo-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C17H20ClN5O2S
 1
1
EC50 = 540 nM
   TI
   LI
   LO
   TS
CP0969952
(3R,4R)-3-(1H-benzo[d]imidazol-2-yl)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C18H15F2N3O2
 1
1
EC50 = 680 nM
   TI
   LI
   LO
   TS
CP0424810
2-ethyl-1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-1H-1,3-benzodiazole
   Show/Hide
C24H26N4O2
 1
1
EC50 = 690 nM
   TI
   LI
   LO
   TS
CP0523092
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-ethylphenyl)urea
   Show/Hide
C20H22N4O2
 1
1
EC50 = 770 nM
   TI
   LI
   LO
   TS
CP0457626
1-[(3R)-1-[(5-bromo-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-2-ethyl-1H-1,3-benzodiazole
   Show/Hide
C22H21BrN4O
 1
1
EC50 = 810 nM
   TI
   LI
   LO
   TS
CP0424809
1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-(2-methylpropyl)-1H-1,3-benzodiazole
   Show/Hide
C26H30N4O2
 1
1
EC50 = 830 nM
   TI
   LI
   LO
   TS
CP0579426
(3S,4R)-3-[[5-(4-chloro-2-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H14ClF3N4O3
 1
1
EC50 = 840 nM
   TI
   LI
   LO
   TS
CP0393823
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(3-fluoro-4-methylphenyl)urea
   Show/Hide
C19H19FN4O2
 1
1
EC50 = 980 nM
   TI
   LI
   LO
   TS
CP0486809
1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-methyl-1H-1,3-benzodiazole
   Show/Hide
C23H24N4O2
 1
1
EC50 = 1020 nM
   TI
   LI
   LO
   TS
CP0407255
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-p-tolylurea
   Show/Hide
C19H20N4O2
 1
1
EC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0968206
(3S,4R)-3-((1H-benzo[d]imidazol-2-yl)amino)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C18H16F2N4O2
 1
1
EC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0541742
1-(1-(4,5-dihydrothiazol-2-yl)-3-isopropyl-2-methyl-5-oxo-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(trifluoromethyl)phenyl)urea
   Show/Hide
C18H20F3N5O2S
 1
1
EC50 = 1470 nM
   TI
   LI
   LO
   TS
CP0440710
2-ethyl-1-[(3R)-1-[(5-fluoro-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C22H21FN4O
 1
1
EC50 = 1490 nM
   TI
   LI
   LO
   TS
CP0440811
1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-(trifluoromethyl)-1H-1,3-benzodiazole
   Show/Hide
C23H21F3N4O2
 1
1
EC50 = 1520 nM
   TI
   LI
   LO
   TS
CP0447652
2-ethyl-1-[(3R)-1-[(5-methoxy-1H-1,3-benzodiazol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C22H23N5O2
 1
1
EC50 = 1870 nM
   TI
   LI
   LO
   TS
CP0579428
(3S,4R)-3-[[3-(4-chlorophenyl)-1,2-oxazol-5-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C20H16ClF2N3O3
 1
1
EC50 = 2200 nM
   TI
   LI
   LO
   TS
CP0970277
(3R,4R)-3-(5-chloro-1H-imidazo[4,5-b]pyridin-2-yl)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C17H13ClF2N4O2
 1
1
EC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0580014
(3S,4R)-3-[[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O3
 1
1
EC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0440810
1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-phenyl-1H-1,3-benzodiazole
   Show/Hide
C28H26N4O2
 1
1
EC50 = 2710 nM
   TI
   LI
   LO
   TS
CP0449432
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-methoxyphenyl)urea
   Show/Hide
C19H20N4O3
 1
1
EC50 = 2730 nM
   TI
   LI
   LO
   TS
CP0446515
2-ethyl-1-[(3S)-1-[(5-methoxy-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C23H24N4O2
 1
1
EC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0546956
(3S,4R)-3-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O3
 1
1
EC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0523091
1-(4-cyanophenyl)-3-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C19H17N5O2
 1
1
EC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0580080
(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-[[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]amino]pyrrolidin-2-one
   Show/Hide
C20H18F2N4O4
 1
1
EC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0502962
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-fluorophenyl)urea
   Show/Hide
C18H17FN4O2
 1
1
EC50 = 4850 nM
   TI
   LI
   LO
   TS
CP0424807
1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-1H-1,3-benzodiazole
   Show/Hide
C22H22N4O2
 1
1
EC50 = 5100 nM
   TI
   LI
   LO
   TS
CP0395311
1-(1-(4,5-dihydrothiazol-2-yl)-3-isopropyl-2-methyl-5-oxo-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-(methylthio)phenyl)urea
   Show/Hide
C18H23N5O2S2
 1
1
EC50 = 5130 nM
   TI
   LI
   LO
   TS
CP0274397
1-(benzo[d][1,3]dioxol-5-yl)-3-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C19H18N4O4
 1
1
EC50 = 5880 nM
   TI
   LI
   LO
   TS
CP0393824
1-(2-chlorophenyl)-3-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C18H17ClN4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0424808
1-(2-chlorophenyl)-3-[1-methyl-3-oxo-2-phenyl-5-(propan-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]urea
   Show/Hide
C20H21ClN4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0499715
1-(1,5-dimethyl-3-oxo-2-phenylpyrazolidin-4-yl)-3-(4-iodophenyl)-1,3-dimethylurea
   Show/Hide
C20H23IN4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0502562
1-(3-chlorophenyl)-3-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)urea
   Show/Hide
C18H17ClN4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0515765
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-fluoro-3-methylphenyl)urea
   Show/Hide
C19H19FN4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0523090
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(thiazol-2-yl)urea
   Show/Hide
C15H15N5O2S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0526722
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-phenylurea
   Show/Hide
C18H18N4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0567905
(3S,4R)-3-[[5-(3-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O3
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0569104
(3S,4R)-3-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C19H15ClF2N4O3
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0579430
(3S,4R)-3-[[5-(4-chlorophenyl)-1-methylpyrazol-3-yl]amino]-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C21H19ClF2N4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0953133
(3R,4R)-3-(4-chloro-1H-benzo[d]imidazol-2-yl)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C18H14ClF2N3O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0969959
(3S,4R)-3-((5-(4-chlorophenyl)-1H-pyrazol-3-yl)amino)-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one
   Show/Hide
C20H17ClF2N4O2
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0424811
2-ethyl-1-[(3R)-1-{[5-(trifluoromethoxy)-1H-indol-2-yl]carbonyl}pyrrolidin-3-yl]-1H-1,3-benzodiazole
   Show/Hide
C23H21F3N4O2
 1
1
EC50 = 12200 nM
   TI
   LI
   LO
   TS
CP0453035
1-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)-3-(4-isopropylphenyl)urea
   Show/Hide
C21H24N4O2
 1
1
EC50 = 12300 nM
   TI
   LI
   LO
   TS
CP0458640
1-[(3R)-1-[(5-chloro-1H-indol-2-yl)carbonyl]pyrrolidin-3-yl]-2-ethyl-1H-1,3-benzodiazole
   Show/Hide
C22H21ClN4O
 1
1
EC50 = 14100 nM
   TI
   LI
   LO
   TS
CP0953132
(3R,4R)-4-(2,6-difluoro-4-methoxyphenyl)-3-(5-methoxy-1H-benzo[d]imidazol-2-yl)pyrrolidin-2-one
   Show/Hide
C19H17F2N3O3
 1
1
EC50 > 5000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0659136
(S)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(5-methoxy-2-pyridinyl)cyclohexyl]methyl]propanamide
   Show/Hide
C32H37N5O4
 2
1 EC50 = 60 nM
2 EC50 = 64 nM
CP0659140
(S)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(3-pyridinyl)cyclohexyl]methyl]propanamide
   Show/Hide
C31H35N5O3
 2
1 EC50 = 270 nM
2 EC50 = 1800 nM
CP0667419
(S)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(2-pyridinyl)cyclohexyl]methyl]propanamide
   Show/Hide
C31H35N5O3
 2
1 EC50 = 450 nM
2 EC50 = 1800 nM
CP0659138
(R)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(2-pyridinyl)cyclohexyl]methyl]propanamide
   Show/Hide
C31H35N5O3
 2
1 EC50 = 490 nM
2 EC50 = 620 nM
CP0659139
(S)-N-[[(1-(2-Fluoro-4-pyridinyl)cyclohexyl]methyl]-3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamide
   Show/Hide
C31H34FN5O3
 2
1 EC50 = 660 nM
2 EC50 = 12600 nM
CP0658395
(R)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(5-methoxy-2-pyridinyl)cyclohexyl]methyl]propanamide
   Show/Hide
C32H37N5O4
 2
1 EC50 = 880 nM
2 EC50 = 920 nM
CP0727506
(R)-3-(1H-Indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[(1-phenylcyclohexyl)methyl]propanamide
   Show/Hide
C32H36N4O3
 1
1 EC50 = 970 nM
CP0659137
(S)-N-[[1-(4-Fluorophenyl)cyclohexyl]methyl]-3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamide
   Show/Hide
C32H35FN4O3
 1
1 EC50 = 1100 nM
CP0046087
(S)-2-[(S)-2-((S)-2-Formylamino-4-methylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid
   Show/Hide
C21H31N3O5S
 1
1 Kd > 300 nM
Clinical Information about the Protein
Target 1 ( FMLP-related receptor I (FPR2) )
Target Type Literature-reported Target
Disease 1 Target-related Disease  1
1 Alzheimer disease [ICD-11: 8A20]
Preclinical Drug(s) 1 Preclinical Drug  1
1 humanin Preclinical
Alzheimer disease
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT00605 FML2_HUMAN Homo sapiens, Human